Literature DB >> 10395353

Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation.

M A Dew1, R L Kormos, L H Roth, S Murali, A DiMartini, B P Griffith.   

Abstract

BACKGROUND: Poor medical compliance has been held responsible for a large proportion of deaths occurring subsequent to initial postoperative recovery. However, beyond clinical reports, there has been little empirical examination of this issue, or of the extent to which major psychiatric disorder and failure to adjust to the transplant predict long-term physical morbidity and mortality. We prospectively examined whether a full range of compliance behaviors and psychiatric outcomes during the first year post-transplant predicted subsequent mortality and physical morbidity through 3 years post-transplant.
METHODS: A total of 145 heart recipients who had received detailed compliance and mental health assessments during the first year post-transplant were followed up at 3 years post-transplant. Interview data and corroborative information from family members were used to determine compliance in multiple domains, psychiatric diagnoses, and psychiatric symptomatology during the first year post-surgery. Medical record reviews were performed to abstract data on acute graft rejection episodes, incident cardiac allograft disease (CAD) and mortality from 1 to 3 years post-transplant.
RESULTS: After controlling for known transplant-related predictors of outcome, multivariate analyses yielded the following significant (p < 0.05) results: (a) risk of acute graft rejection was 4.17 times greater among recipients who were not compliant with medications; (b) risk of incident CAD was elevated by persistent depression (Odds Ratio, OR = 4.67), persistent anger-hostility (OR = 8.00), medication noncompliance (OR = 6.91), and obesity (OR = 9.92); and (c) risk of mortality was increased if recipients met criteria for Post-Traumatic Stress Disorder related to the transplant (OR = 13.74).
CONCLUSIONS: The findings, plus data we have previously reported that showed which patients are most likely to have compliance and psychiatric problems early post-transplant, suggest that interventions focused on maximizing patients' psychosocial status in these areas may further improve long-term physical health outcomes in this population.

Entities:  

Mesh:

Year:  1999        PMID: 10395353     DOI: 10.1016/s1053-2498(98)00044-8

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  51 in total

Review 1.  Psychosocial Challenges in Solid Organ Transplantation.

Authors:  Kristin Kuntz; Stephan R Weinland; Zeeshan Butt
Journal:  J Clin Psychol Med Settings       Date:  2015-09

Review 2.  Nonadherence in the Advanced Heart Failure Population.

Authors:  Jonathan Gandhi; Andrew McCue; Robert Cole
Journal:  Curr Heart Fail Rep       Date:  2016-04

3.  Adherence to the medical regimen during the first two years after lung transplantation.

Authors:  Mary Amanda Dew; Andrea F Dimartini; Annette De Vito Dabbs; Rachelle Zomak; Sabina De Geest; Fabienne Dobbels; Larissa Myaskovsky; Galen E Switzer; Mark Unruh; Jennifer L Steel; Robert L Kormos; Kenneth R McCurry
Journal:  Transplantation       Date:  2008-01-27       Impact factor: 4.939

4.  Religion and the Catholic church's view on (heart) transplantation: a recent statement of Pope Benedict XVI and its practical impact.

Authors:  Ernst R Schwarz; Salvatore Rosanio
Journal:  J Relig Health       Date:  2011-09

Review 5.  A systematic review of immunosuppressant adherence interventions in transplant recipients: Decoding the streetlight effect.

Authors:  S Duncan; R A Annunziato; C Dunphy; D LaPointe Rudow; B L Shneider; E Shemesh
Journal:  Pediatr Transplant       Date:  2017-12-07

6.  Long-Term Follow-up of a Randomized Controlled Trial Evaluating a Mobile Health Intervention for Self-Management in Lung Transplant Recipients.

Authors:  E M Rosenberger; A J DeVito Dabbs; A F DiMartini; D P Landsittel; J M Pilewski; M A Dew
Journal:  Am J Transplant       Date:  2016-10-31       Impact factor: 8.086

Review 7.  Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

Authors:  Catherine C Crone; Geoffrey M Gabriel
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 8.  Anxiety disorders and all-cause mortality: systematic review and meta-analysis.

Authors:  Beyon Miloyan; Adam Bulley; Karen Bandeen-Roche; William W Eaton; Daniela C Gonçalves-Bradley
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-09-14       Impact factor: 4.328

Review 9.  Depression and Anxiety as Risk Factors for Morbidity and Mortality After Organ Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Mary Amanda Dew; Emily M Rosenberger; Larissa Myaskovsky; Andrea F DiMartini; Annette J DeVito Dabbs; Donna M Posluszny; Jennifer Steel; Galen E Switzer; Diana A Shellmer; Joel B Greenhouse
Journal:  Transplantation       Date:  2015-05       Impact factor: 4.939

Review 10.  [Management of older patients following solid organ transplantation].

Authors:  Regina Elisabeth Roller-Wirnsberger; Gerhard Hubert Wirnsberger
Journal:  Z Gerontol Geriatr       Date:  2015-12-09       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.